{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:10:57Z","timestamp":1790622657166,"version":"4.1.0"},"reference-count":37,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"5","license":[{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,14]]},"abstract":"<jats:title>ABSTRACT.<\/jats:title>\n<jats:p>The recommended schedule for killed oral cholera vaccine (OCV) is two doses, 2 weeks apart. However, during vaccine campaigns, the second round is often delayed by several months. Because more information is needed to document antibody responses when the second dose is delayed, we conducted an open-label, phase 2, noninferiority clinical trial of OCV. One hundred eighty-six participants were randomized into three dose-interval groups (DIGs) to receive the second dose 2 weeks, 6 months, or 11.5 months after the first dose. The DIGs were stratified into three age strata: 1 to 4, 5 to 14, and &gt; 14 years. Inaba and Ogawa vibriocidal titers were assessed before and after vaccination. The primary analysis was geometric mean titer (GMT) 2 weeks after the second dose. Data for primary analysis was available from 147 participants (54, 44, and 49 participants from the three DIGs respectively). Relative to the 2-week interval, groups receiving a delayed second dose had significantly higher GMTs after the second dose. Two weeks after the second dose, Inaba GMTs were 55.1 190.3, and 289.8 and Ogawa GMTs were 70.4, 134.5, and 302.4 for the three DIGs respectively. The elevated titers were brief, returning to lower levels within 3 months. We conclude that when the second dose of killed oral cholera vaccine was given after 6 or 11.5 months, vibriocidal titers were higher than when given after the standard period of 2 weeks. This provides reassurance that a delayed second dose does not compromise, but rather enhances, the serological response to the vaccine.<\/jats:p>","DOI":"10.4269\/ajtmh.22-0462","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T17:34:09Z","timestamp":1668620049000},"page":"974-983","source":"Crossref","is-referenced-by-count":7,"title":["An Age-stratified, Randomized Immunogenicity Trial of Killed Oral Cholera Vaccine with Delayed Second Dose in Cameroon"],"prefix":"10.4269","volume":"107","author":[{"given":"J\u00e9r\u00f4me","family":"Ateudjieu","sequence":"first","affiliation":[{"name":"MA Sante, Yaound\u00e9, Cameroon;"},{"name":"Department of Public Health, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Cameroon;"},{"name":"Clinical Research Unit, Division of Health Operations Research, Ministry of Public Health, Cameroon;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Sack","sequence":"additional","affiliation":[{"name":"Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia Sonkeng","family":"Nafack","sequence":"additional","affiliation":[{"name":"MA Sante, Yaound\u00e9, Cameroon;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoming","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketina Hirma","family":"Tchio-Nighie","sequence":"additional","affiliation":[{"name":"MA Sante, Yaound\u00e9, Cameroon;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herve","family":"Tchokomeni","sequence":"additional","affiliation":[{"name":"MA Sante, Yaound\u00e9, Cameroon;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landry Beyala","family":"Bita\u2019a","sequence":"additional","affiliation":[{"name":"MA Sante, Yaound\u00e9, Cameroon;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Ntsekendio","family":"Nyibio","sequence":"additional","affiliation":[{"name":"MA Sante, Yaound\u00e9, Cameroon;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Guenou","sequence":"additional","affiliation":[{"name":"MA Sante, Yaound\u00e9, Cameroon;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kedia Mayah","family":"Mondung","sequence":"additional","affiliation":[{"name":"MA Sante, Yaound\u00e9, Cameroon;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank Forex Kiadjieu","family":"Dieumo","sequence":"additional","affiliation":[{"name":"MA Sante, Yaound\u00e9, Cameroon;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanne Minone","family":"Ngome","sequence":"additional","affiliation":[{"name":"Department of Bacteriology-Parasitology-Mycology Laboratory, Centre Pasteur of Cameroon (CPC), Yaound\u00e9, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey N.","family":"Murt","sequence":"additional","affiliation":[{"name":"Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malathi","family":"Ram","sequence":"additional","affiliation":[{"name":"Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda K.","family":"Debes","sequence":"additional","affiliation":[{"name":"Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"b1","series-title":"PLoS Negl Trop Dis","doi-asserted-by":"publisher","first-page":"e0003832","DOI":"10.1371\/journal.pntd.0003832","article-title":"Updated global burden of cholera in endemic countries","volume":"9","author":"Ali","year":"2015"},{"key":"b2","series-title":"Am J Trop Med Hyg","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.4269\/ajtmh.20-0741","article-title":"Refugee settlements and cholera risks in Uganda, 2016\u20132019","volume":"104","author":"Bwire","year":"2021"},{"key":"b3","series-title":"Am J Trop Med Hyg","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.4269\/ajtmh.16-0300","article-title":"Factors associated with fatal outcomes following cholera-like syndrome in far north region of Cameroon: a community-based survey","volume":"95","author":"Djouma","year":"2016"},{"key":"b4","series-title":"BMC Health Serv Res","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1186\/s12913-019-4315-7","article-title":"Health facility preparedness for cholera outbreak response in four cholera-prone districts in Cameroon: a cross sectional study","volume":"19","author":"Ateudjieu","year":"2019"},{"key":"b5","series-title":"PLoS Negl Trop Dis","doi-asserted-by":"publisher","first-page":"e0006652","DOI":"10.1371\/journal.pntd.0006652","article-title":"The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: a disease modeling and economic analysis","volume":"12","author":"Khan","year":"2018"},{"key":"b6","series-title":"Lancet Infect Dis","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/S1473-3099(17)30359-6","article-title":"Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis","volume":"17","author":"Bi","year":"2017"},{"key":"b7","series-title":"Vaccine","first-page":"A132","article-title":"Global oral cholera vaccine use, 2013\u20132018","volume":"38 (Suppl 1)","author":"Pezzoli","year":"2020"},{"key":"b8","series-title":"Wkly Epidemiol Rec","first-page":"477","article-title":"Cholera vaccines: WHO position paper\u2014August 2017","volume":"92","year":"2017"},{"key":"b9","series-title":"Hum Vaccin Immunother","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/21645515.2016.1245250","article-title":"Achievements and challenges for the use of killed oral cholera vaccines in the global stockpile era","volume":"13","author":"Desai","year":"2017"},{"key":"b10","series-title":"Lancet Infect Dis","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/S1473-3099(18)30108-7","article-title":"Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial","volume":"18","author":"Qadri","year":"2018"},{"key":"b11","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1056\/NEJMc1711583","article-title":"Single-dose cholera vaccine in response to an outbreak in Zambia","volume":"378","author":"Ferreras","year":"2018"},{"key":"b12","series-title":"Bull World Health Organ","doi-asserted-by":"publisher","first-page":"86","DOI":"10.2471\/BLT.16.189241","article-title":"Implementation research: reactive mass vaccination with single-dose oral cholera vaccine, Zambia","volume":"96","author":"Poncin","year":"2018"},{"key":"b13","series-title":"PLoS One","doi-asserted-by":"publisher","first-page":"e0219040","DOI":"10.1371\/journal.pone.0219040","article-title":"Delayed second dose of oral cholera vaccine administered before high-risk period for cholera transmission: cholera control strategy in Lusaka, 2016","volume":"14","author":"Ferreras","year":"2019"},{"key":"b14","series-title":"PLoS Med","doi-asserted-by":"publisher","first-page":"e1001867","DOI":"10.1371\/journal.pmed.1001867","article-title":"The impact of a one-dose versus two-dose oral cholera vaccine regimen in outbreak settings: a modeling study","volume":"12","author":"Azman","year":"2015"},{"key":"b15","series-title":"PLoS Negl Trop Dis","doi-asserted-by":"publisher","first-page":"e0003574","DOI":"10.1371\/journal.pntd.0003574","article-title":"Flexibility of oral cholera vaccine dosing-a randomized controlled trial measuring immune responses following alternative vaccination schedules in a cholera hyper-endemic zone","volume":"9","author":"Kanungo","year":"2015"},{"key":"b16","series-title":"Vaccine","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/j.vaccine.2019.12.034","article-title":"Augmented immune responses to a booster dose of oral cholera vaccine in Bangladeshi children less than 5 years of age: revaccination after an interval of over three years of primary vaccination with a single dose of vaccine","volume":"38","author":"Chowdhury","year":"2020"},{"key":"b17","series-title":"Vaccine","doi-asserted-by":"publisher","first-page":"4516","DOI":"10.1016\/j.vaccine.2021.06.034","article-title":"Serum vibriocidal responses when second doses of oral cholera vaccine are delayed 6 months in Zambia","volume":"39","author":"Mwaba","year":"2021"},{"key":"b18","series-title":"BMC Infect Dis","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12879-018-2981-4","article-title":"Efficacy of a bivalent killed whole-cell cholera vaccine over five years: a re-analysis of a cluster-randomized trial","volume":"18","author":"Fong","year":"2018"},{"key":"b19","series-title":"Open Forum Infect Dis","first-page":"ofz057","article-title":"Vibriocidal titer and protection from cholera in children","volume":"6","author":"Ritter","year":"2019"},{"key":"b20","series-title":"Expert Rev Vaccines","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/14760584.2017.1291348","article-title":"PaxVax CVD 103-HgR single-dose live oral cholera vaccine","volume":"16","author":"Levine","year":"2017"},{"key":"b21","series-title":"PLoS Negl Trop Dis","doi-asserted-by":"publisher","first-page":"e2828","DOI":"10.1371\/journal.pntd.0002828","article-title":"Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti","volume":"8","author":"Charles","year":"2014"},{"key":"b22","year":"2022"},{"key":"b23","series-title":"Lancet Infect Dis","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/S1473-3099(13)70273-1","article-title":"5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial","volume":"13","author":"Bhattacharya","year":"2013"},{"key":"b24","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/0140-6736(90)90080-O","article-title":"Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up","volume":"335","author":"Clemens","year":"1990"},{"key":"b25","series-title":"Vaccine","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1016\/j.vaccine.2017.09.025","article-title":"Comparison of two control groups for estimation of oral cholera vaccine effectiveness using a case-control study design","volume":"35","author":"Franke","year":"2017"},{"key":"b26","series-title":"Bull World Health Organ","first-page":"909","article-title":"Local and systemic antibody responses and immunological memory in humans after immunization with cholera B subunit by different routes","volume":"62","author":"Svennerholm","year":"1984"},{"key":"b27","series-title":"Sci Rep","doi-asserted-by":"publisher","first-page":"35742","DOI":"10.1038\/srep35742","article-title":"Immune responses to an oral cholera vaccine in internally displaced persons in South Sudan","volume":"6","author":"Iyer","year":"2016"},{"key":"b28","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1510330","article-title":"Efficacy of a single-dose, inactivated oral cholera vaccine in Bangladesh","volume":"374","author":"Qadri","year":"2016"},{"key":"b29","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1093\/cid\/cix1039","article-title":"Immunogenicity and protection from a single dose of internationally available killed oral cholera vaccine: a systematic review and metaanalysis","volume":"66","author":"Lopez","year":"2018"},{"key":"b30","series-title":"Vaccine","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1016\/j.vaccine.2016.04.055","article-title":"Induction of long term mucosal immunological memory in humans by an oral inactivated multivalent enterotoxigenic Escherichia coli vaccine","volume":"34","author":"Lundgren","year":"2016"},{"key":"b31","series-title":"Hum Vaccin Immunother","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1080\/21645515.2019.1605278","article-title":"Long intervals between two doses of HPV vaccines and magnitude of the immune response: a post hoc analysis of two clinical trials","volume":"15","author":"Gilca","year":"2019"},{"key":"b32","series-title":"JAMA","first-page":"2100","article-title":"From the Centers for Disease Control and Prevention. Alternate two-dose hepatitis B vaccination schedule for adolescents aged 11\u201315 years","volume":"283","year":"2000"},{"key":"b33","doi-asserted-by":"publisher","author":"Payne","year":"2001","DOI":"10.1016\/j.vaccine.2021.02.022"},{"key":"b34","series-title":"Vaccine","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1111\/apa.14932","article-title":"Sex difference in the immunogenicity of the quadrivalent human papilloma virus vaccine: systematic review and meta-analysis","volume":"39","author":"Aldakak","year":"2021"},{"key":"b35","series-title":"Acta Paediatr","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/tropicalmed6020076","article-title":"Biological sex influences antibody responses to routine vaccinations in the first year of life","volume":"109","author":"Zimmermann","year":"2020"},{"key":"b36","series-title":"Trop Med Infect Dis","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1371\/journal.pntd.0007057","article-title":"Cholera hot-spots and contextual factors in Burundi, planning for elimination","volume":"6","author":"Debes","year":"2021"},{"key":"b37","series-title":"PLoS Negl Trop Dis","doi-asserted-by":"publisher","first-page":"e0007057","DOI":"10.1371\/journal.pntd.0003832","article-title":"Bivalent oral cholera vaccination induces a memory B cell response to the V. cholerae O1-polysaccharide antigen in Haitian adults","volume":"13","author":"Falkard","year":"2019"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/107\/5\/article-p974.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/107\/5\/article-p974.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/107\/5\/article-p974.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T17:34:25Z","timestamp":1668620065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/107\/5\/article-p974.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,14]]},"references-count":37,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.22-0462","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,14]]}}}